Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

The Spanish Society of Probiotics and Prebiotics is created with leadership of VHIR’s researchers

On September 21 was created the Spanish Society for Probiotics and Prebiotics (SEPyP), at Vall d’Hebron University Hospital, host of the new entity. The society will be chaired by Dr. Francisco Guarner, and in its board also will be Dr. Fernando Azpiroz, member and responsable respectively of the di

News

VHIR achieves a high success rate in the call for ISCIII health research projects

Vall d'Hebron Research Institute (VHIR) is the second Catalan biomedical center with more projects awarded in the call for health research projects in 2011 of the Instituto de Salud Carlos III (ISCIII). VHIR has been granted in 27 of its 55 projects presented, representing 49.09% of the success rate

News

Dr. Boada at World Alzheimer's Day

Coinciding with World Alzheimer's Day, Dr. Mercè Boada, head of the group of Alzheimer at Vall d'Hebron Research Institute (VHIR) and director of the ACE Foundation has participated in the program 'Els Matins' of TV3, and has been interviewed for various stories in other media. In addition, Dr. Boad

News

Bisphenol A disrupts the development of ovules in vitro and may increase the risk of Down syndrome

Researchers at the Universitat Autònoma of Barcelona in collaboration with the Department of Obstetrics and Fetal Tissue Bank from Vall d'Hebron University Hospital have analyzed the effects of Bisphenol A (BPA), a polymer widely used for the manufacture of plastics, crop ovaries in vitro. This work

News

VHIR Predoctoral Fellowships

Programa d’ajuts predoctorals per a la formació de personal investigador del Vall d’Hebron Institut de RecercaObjecte: selecció de 4 candidats per realitzar treballs de recerca dins del camp de la recerca biomèdica bàsica, clínica, epidemiològica, així com en gestió i avaluació de serveis i tecnolog

News

VHIR's director meets with the Minister Garmendia as general secretary of COSCE

Dr. Joan Comella, director of the Vall d'Hebron Research Institute (VHIR), met on the afternoon of September 12 the Minister of Science and Innovation, Cristina Garmendia, in his role of secretary general of the Confederation of Scientific Societies of Spain (COSCE), along with its president Carlos

News

Discovered a new mechanism that regulates priority cell signaling pathways

Researchers at Vall d'Hebron Research Institute (VHIR) have discovered a new cellular signaling mechanism that had been unknown until this moment. It is the coordinated use of two languages that are used by the cell to send internal signals in a precise and targeted way. This mechanism does not repl

News

Dr. Pozo explains the latest advances in headache

Coinciding with the World Headache Day, Dr. Patricia Pozo Rosich, leaders of research group in headache and neurological pain at Vall d'Hebron Research Institute (VHIR ) explains the latest research on this subject in the news on TVE. Three and a half million of the Spanish population suffers migrai

News

Poor control of blood sugar in diabetics explains the low activity of some defense cells

A study of the Vall d'Hebron Research Institute (VHIR) has showed the relationship between low phagocytic activity of macrophages (the body's defense cells) and poor control of glucose in patients with type II diabetes. This finding may explain the increased susceptibility of diabetics to suffer all

News

Found a recurrent fusion protein in colorectal tumor

A team of researchers from Vall d'Hebron University Hospital, coordinated by Dr. Josep Tabernero, Chief of Oncology, participates in the first sequencing of nine colorectal tumor genomes that have been compared with nine complete genomes of healthy tissue from the same patients. The results of the i

News

Discovered how works a key protein that could be target for new treatments for CLL

A recent study of Vall d'Hebron Research Institute (VHIR) has shown the mechanism that explains why the presence of a protein -ZAP-70- determines the prognosis of chronic lymphocytic leukemia (the most common among adults in the western world) and has given its key role as a potential therapeutic ta

News

VHIR participates in Multiple sclerosis research that doubles number of genes associated with the disease

Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of a very debilitating neurological disease. Many of the genes implicated in the study are relevant to the immune system, shedding light onto the immunological pathways that under

News

Dr. Comella and Dr. Comabella debate on research at Onda Cero radio

Dr Joan Comella, director of Vall d'Hebron Research Institute (VHIR), and Dr. Manuel Comabella, member of the clinical neuroimmunology grup at VHIR and representing CEM-Cat, participated Monday night in a discussion on research in Catalonia that organized the program 'Pont Barcelona-Madrid' at Onda

News

The triple perspective of cardiology at VHIR

The journal 'Diario Médico' reviews the activity of the circulatory disease, and in general the area of the heart, directed by Dr. David Garcia-Dorado at Vall d'Hebron Research Institute (VHIR). The group, considered of international scientific excellence and reference, add a large number of publica

News

UPC/CIT and VHIR meet to explore future collaborations

A delegation from the Universitat Politècnica de Catalunya (UPC) belonging to its Center for Innovation and Technology (CIT), have met at Vall d'Hebron Research Institute (VHIR) with researchers and professionals from Vall d'Hebron University Hospital with innovative projects. The meeting's objectiv

News

VHIR and Step by Step will collaborate on research projects in the field of spinal cord injury

Vall d'Hebron Research Institute (VHIR) and the Foundation Step by Step, as part of the annual meeting of its board, have signed a cooperation agreement to promote and support new research in the field of spinal cord injury. Both institutions enable the strengthening of research, with particular att

News

Dr Joan Comella, the new Secretary General of the COSCE

The director of Vall d'Hebron Research Institute (VHIR), Dr. Joan Comella, has been elected Secretary General of the Confederation of Scientific Associations of Spain (COSCE). The new president of the confederation will be Professor of the Universidad Complutense de Madrid, Carlos Andradas, who is r

News

2nd edition of the Interuniversity Master on 'Direction and management of R+D+i in Health Sciences'

Instituto de Salud Carlos III (ISCIII), in collaboration with UAH and UNED, organize the 2nd edition of the Interuniversity Master on 'Management of R+D+i in Health Sciences' to be held between November 2011 and March 2013. In the first edition, to get exposure to a representative sample of institut

News

Vall d'Hebron and MONDRAGON Health sign an agreement of collaboration in R+D+i

Vall d'Hebron University Hospital, Fundació Institut Universitari Vall d'Hebron Research Institute (VHIR) and MONDRAGON Health signed today a new strategic partnership oriented to R+D+I to promote collaboration in the fields of science and technology in activities of mutual interest to contribute to

News

Dr. Reventós invited to the Oncology and Biotechnology Forum

Dr. Jaume Reventós, head of the Research Unit of Biomedical and Translational and Pediatric Oncology at Vall d'Hebron Institut de Recerca (VHIR) was invited to present the work 'Discovery of new diagnostic biomarkers for endometrial carcinoma in uterine aspirate: an example of academia-industry part